Travere Therapeutics, Inc. (TVTX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 392.68M | 437.56M | 371.11M | 379.57M | 374.17M | 416.7M | 324.74M | 368.98M | 481.08M | 616.77M | 686.23M | 542.05M |
| Cash & Short-Term Investments | 264.68M | 322.8M | 254.53M | 319.54M | 322.24M | 370.7M | 277.44M | 325.4M | 441.04M | 566.85M | 634.64M | 491.34M |
| Cash Only | 78.36M | 93.03M | 110.93M | 75.15M | 61.9M | 58.53M | 36.41M | 32.29M | 43.25M | 58.18M | 144.24M | 70.87M |
| Short-Term Investments | 186.31M | 229.76M | 143.6M | 244.38M | 260.35M | 312.17M | 241.03M | 293.11M | 397.79M | 508.68M | 490.4M | 420.46M |
| Accounts Receivable | 87.3M | 81.43M | 82.98M | 38.72M | 34.38M | 27.12M | 25.17M | 24.47M | 22.73M | 21.18M | 14.57M | 20.4M |
| Days Sales Outstanding | 59.69 | 58.32 | 33.96 | 29.06 | 33.86 | 32.16 | 36.3 | 39.68 | 48.29 | 36.5 | 43.36 | 62.09 |
| Inventory | 6.36M | 5.88M | 5.55M | 4.09M | 3.93M | 6.2M | 6.36M | 5.98M | 4.53M | 9.41M | 20.77M | 18.77M |
| Days Inventory Outstanding | - | 205.82 | 279.71 | 239.97 | 97.44 | 226.23 | 348.88 | 38.54 | 421.78 | 84.58 | 1.41K | 798.35 |
| Other Current Assets | 34.35M | 27.46M | 28.05M | 17.22M | 13.62M | 12.69M | 15.78M | 13.14M | 12.77M | 19.34M | 16.24M | 11.56M |
| Total Non-Current Assets | 162.51M | 167.63M | 167.47M | 175.74M | 174.63M | 177.42M | 179.67M | 182.19M | 182.52M | 172.14M | 146.67M | 194.34M |
| Property, Plant & Equipment | 13.29M | 14.6M | 15.78M | 16.9M | 18.05M | 19.63M | 21.82M | 23.05M | 24.21M | 25.54M | 26.8M | 28.13M |
| Fixed Asset Turnover | 9.12x | 8.54x | 10.09x | 6.55x | 4.34x | 3.61x | 2.80x | 2.29x | 1.66x | 1.72x | 1.35x | 1.12x |
| Goodwill | 0 | 753K | 0 | 753K | 753K | 800K | 747K | 800K | 800K | 753K | 800K | 900K |
| Intangible Assets | 110.04M | 113.11M | 109.44M | 104.85M | 103.06M | 103.22M | 103.46M | 104.42M | 100.43M | 103.69M | 106.15M | 153.52M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 39.17M | 39.16M | 42.25M | 53.24M | 52.76M | 53.77M | 53.64M | 53.92M | 57.08M | 42.16M | 12.91M | 11.79M |
| Total Assets | 555.19M | 605.19M | 538.58M | 555.31M | 548.8M | 594.13M | 504.41M | 551.12M | 663.55M | 788.91M | 832.85M | 736.43M |
| Asset Turnover | 0.22x | 0.23x | 0.30x | 0.21x | 0.14x | 0.14x | 0.12x | 0.09x | 0.06x | 0.06x | 0.05x | 0.04x |
| Asset Growth % | 1.16% | 1.86% | 6.77% | 0.76% | -17.29% | -24.69% | -39.44% | -25.16% | -17.9% | 17.3% | 14.68% | -5.52% |
| Total Current Liabilities | 125.44M | 159.9M | 135.07M | 189.54M | 182.46M | 200.75M | 190.04M | 121.27M | 173.23M | 177.91M | 139.43M | 135.71M |
| Accounts Payable | 12.91M | 24.8M | 18.23M | 19.13M | 15.37M | 23.53M | 23.2M | 25.84M | 16.73M | 41.67M | 24.74M | 19.91M |
| Days Payables Outstanding | - | 775.23 | 1.08K | 1.03K | 374.2 | 841.96 | 1.39K | 156.12 | 1.77K | 186.09 | 1.59K | 1.15K |
| Short-Term Debt | 6.02M | 5.88M | 5.73M | 68.84M | 68.76M | 68.68M | 68.6M | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 2.81M | 3.8M | 5.38M | 6.46M | 7.1M | 8.96M | 10.24M |
| Other Current Liabilities | 106.51M | 87.71M | 111.11M | 95.97M | 15.76M | 49.46M | 60.85M | 27.75M | 24.14M | 94.32M | 32.09M | 33.63M |
| Current Ratio | 3.13x | 2.74x | 2.75x | 2.00x | 2.05x | 2.08x | 1.71x | 3.04x | 2.78x | 3.47x | 4.92x | 3.99x |
| Quick Ratio | 3.08x | 2.70x | 2.71x | 1.98x | 2.03x | 2.04x | 1.68x | 2.99x | 2.75x | 3.41x | 4.77x | 3.86x |
| Cash Conversion Cycle | - | -511.09 | -770.56 | -763.26 | -242.89 | -583.57 | -1K | -77.9 | -1.3K | -65.02 | -139.1 | -287.78 |
| Total Non-Current Liabilities | 331.02M | 330.46M | 329.94M | 333.02M | 333.52M | 334.3M | 344.83M | 414.71M | 416.25M | 410.19M | 413.65M | 484.23M |
| Long-Term Debt | 321.64M | 322.86M | 324.01M | 311.02M | 310.66M | 310.31M | 309.96M | 378.13M | 377.69M | 377.26M | 376.83M | 376.4M |
| Capital Lease Obligations | 0 | 11.13M | 0 | 14.12M | 15.58M | 17.19M | 18.58M | 19.94M | 21.29M | 22.61M | 23.86M | 25.11M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 9.38M | -3.53M | 5.93M | 7.88M | 7.27M | 6.8M | 16.29M | 16.64M | 16.38M | 8.48M | 8.38M | 75.94M |
| Total Liabilities | 456.46M | 490.36M | 465.02M | 522.56M | 515.98M | 535.05M | 534.86M | 535.97M | 589.48M | 588.1M | 553.08M | 619.94M |
| Total Debt | 327.66M | 339.87M | 329.75M | 399.57M | 400.46M | 401.58M | 402.43M | 403.23M | 404.02M | 404.78M | 405.48M | 406.17M |
| Net Debt | 249.3M | 246.83M | 218.82M | 324.42M | 338.57M | 343.05M | 366.02M | 370.94M | 360.76M | 346.61M | 261.23M | 335.3M |
| Debt / Equity | 3.32x | 2.96x | 4.48x | 12.20x | 12.20x | 6.80x | - | 26.62x | 5.45x | 2.02x | 1.45x | 3.49x |
| Debt / EBITDA | - | - | 8.10x | 292.51x | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | 5.37x | 237.50x | - | - | - | - | - | - | - | - |
| Interest Coverage | -15.91x | -8.17x | 10.35x | -3.47x | -13.42x | -20.42x | -18.75x | -23.95x | -47.49x | -30.38x | -30.63x | -34.83x |
| Total Equity | 98.73M | 114.83M | 73.56M | 32.75M | 32.82M | 59.08M | -30.45M | 15.15M | 74.07M | 200.81M | 279.77M | 116.48M |
| Equity Growth % | 200.79% | 94.37% | 341.56% | 116.19% | -55.69% | -70.58% | -110.89% | -87% | -60.84% | 368.62% | 177.89% | -25.67% |
| Book Value per Share | 1.07 | 1.27 | 0.72 | 0.37 | 0.37 | 0.71 | -0.39 | 0.20 | 0.96 | 2.63 | 3.67 | 1.53 |
| Total Shareholders' Equity | 98.73M | 114.83M | 73.56M | 32.75M | 32.82M | 59.08M | -30.45M | 15.15M | 74.07M | 200.81M | 279.77M | 116.48M |
| Common Stock | 9K | 9K | 9K | 9K | 9K | 9K | 8K | 8K | 8K | 7K | 7K | 7K |
| Retained Earnings | -1.51B | -1.47B | -1.48B | -1.5B | -1.49B | -1.45B | -1.39B | -1.33B | -1.26B | -1.13B | -1.04B | -1.19B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.06M | -1.19M | -1.05M | -812K | -843K | -80K | -1.02M | -1.63M | -1.89M | -1.46M | -3.65M | -3.85M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |